维普期刊资源整合服务平台（V6.5）

104篇 您的检索式：作者名="SCHUCHTER"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Survival in BRAF V600-mutant advanced melanoma treated with Muraenidae显示文摘	Sosman 1 A Kim K B Schuchter L	2012	N Engl 1 Med2012，366，8：	1
2	American Society of Clinical Oncology : clinical practice guidelines for the use ofchemotherapy and radiotherapy protectants 显示文摘	Hensley ML Schuchter LM Lindley C	1999	J Clin Oncol1999，17，10：	1
3	Final results of E2603: a double-blind, randomized phase Ⅲ trial com- paring carboplatin (C)/paclitaxel (P) with or without so- rafenib (S) in metastatic melanoma显示文摘	Flaherty KT Lee S J Schuchter LM	2010	J Clin Oncol2010，28，15：	1
4	Preliminary results of a randomized phase Ⅱ study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma 显示文摘	Amaravadi RK Schuchter LM Kramer A	2006	Proc Am Soc Clin Oncol2006，24，：	1
5	Successful treatment of murine melanoma with bryostatin 1显示文摘	Esa AH May S	1991	Cancer Res1991，51，2：	1
6	Orbital lloor reconstruction with flexible Ethisorb patches:a retrospective long-term follow-up study显示文摘	Jank S Emshoff R Schuchter B	2003	Oral Surg Oral Med Oral Pathol Oral Radiol Endod2003，95，1：	1
7	Phase Ⅱ trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases 显示文摘	Amaravadi RK Schuchter LM McDermott DF	2009	Clin Cancer Res2009，15，24：	1
8	American Society of Clinical Oncology: clinical practice guidelines for the use of chemotherapy and radiotherapy protectants 显示文摘	Schuchter LM Lindley C	1999	J Clin Oncol1999，171，10：	1
9	American Society of Clinical Oncology Clincal practice guidelines for the use of chemotherapy and radiotherapy 显示文摘	HENSLEY M L SCHUCHTER L M LINDLEY C	1999	J Clin Oncol1999，17，10：	1
10	The first trimester ' combined test ' for the detection of Down syndrome pregnancies in 4939 unselected pregnancies显示文摘	Schuchter K Hafner E Stangl G	2002	Prenat Diagn2002，22，3：	1
11	The current status of toxicity protectants in canc er therapy显示文摘	SCHUCHTER LM LUGINBUHL WE MEROPL NJ	1992	SeminOncol1992，19，：	1
12	Early stage(I,II,III)melanoma显示文摘	Sondak VK Ross MI Schuchter LM	2001	Curr Treat Options Oncol2001，2，3：	1
13	Phase Ⅱ trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases 显示文摘	Amaravadi RK Schuchter LM McDermott DF	2009	Clin Cancer Res2009，15，24：	1
14	Phase Ⅰ/Ⅱ trial of BAY43-9006, carboplatin(C)and paclitax(P) demonstrates preliminary antitumor activity in the expansion cohort of patients with metastatic melanoma (abstract)显示文摘	Flaherty KT Brose M Schuchter L	2004	Proc Am Soc Clin Oncol2004，22，：	1
15	BRIM-2 : an open- label,multicenter phase II study of vemurafenib in previ- ously treated patients with BRAF V600E mutation-posi- tive metastatic melanoma显示文摘	Ribas A Kim KB Schuchter LM	2011	J Clin Oncol2011，29，：	1
16	American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants显示文摘	HENSLEY ML SCHUCHTER LM LINDLEY C	1999	J Clin Oncol1999，171，：	1
17	Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib显示文摘	SOSMANJA KIM KB SCHUCHTER L	2012	N EnglJ Med2012，366，8：	1
18	Update of recommen-dations for the use of chemotherapy and radiotherapy protectants:clini-cal practice guidelines of the American Society of Clinical Oncology显示文摘	Schuchter LM Hensley ML Meropol NJ	2002	J Clin Oncol2002，20，12：	1
19	The current status of WR-2721(Amifostine):A chemotherapy and radiation therapy protector显示文摘	SCHUCHTER L M GLICK J		0，，03：	1
20	BRIM-2:An open-label,muhicenter phase Ⅱ study of vemurafenib in previously treated patients with BRAF V600E mutationpositive metastatic melanoma显示文摘	Ribas A Kim KB Schuchter LM		0，，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示